Imaging Studies II: Positron Emission Tomography and Scintigraphy
Clinical Trials
Clinical Trials: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice
Published on: October 25, 2024
1RIKEN Center for Molecular Imaging Science, Kobe, Japan. yywata@riken.jp
Positron emission tomography (PET) molecular imaging advances drug development by enabling in vivo studies from animals to humans. This technology tracks pharmacokinetics (PK) and pharmacodynamics (PD) in target tissues, accelerating therapeutic innovation.
Area of Science: